Trials / Withdrawn
WithdrawnNCT02871271
Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness
Open-Label Pilot Study to Evaluate the Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness in Healthy Subjects
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the tolerability and benefit of IQP-AS-121 on reducing fatigue and tiredness and to improve mental alertness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IQP-AS-121 |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-03-01
- Completion
- 2017-09-01
- First posted
- 2016-08-18
- Last updated
- 2020-02-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02871271. Inclusion in this directory is not an endorsement.